NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹235 Cr | ₹213 Cr | ₹163 Cr | ₹173 Cr | ₹125 Cr |
What is the latest Total Current Assets ratio of NGL FINECHEM ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹213 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹173 Cr |
| Mar2021 | ₹125 Cr |
How is Total Current Assets of NGL FINECHEM Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹235 Cr | 10.68 | |
| Mar2024 | ₹213 Cr | 30.75 | |
| Mar2023 | ₹163 Cr | -6.25 | |
| Mar2022 | ₹173 Cr | 39.32 | |
| Mar2021 | ₹125 Cr | - | |
Compare Total Current Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,491.4 Cr | 7.1% | 41.9% | 108.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 7.1% |
41.9% |
108.7% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses